Member Info for maidit308

yes C34''we saw one of those before that massive breakout from £1.45p last week
the trade then was well over asked, price at 1.72p

this one was priced at 2.82p, again well over ask ATM..

will it go there again shortly ???

time will tell

because although we are doing extremely well on the revenue Front
in all territory we have lost our Announce Announce Announce shine, that we had,
the Market only seems to like the excitement of subscribers numbers
and podcast on a monthly bases, and not the 3 monthly they have now change it to
and also the end of warrant churn and overhang cleared, end of March
was toted by ME on that last interview, and we are still waiting on that TR1 RNS
so that SP can start reflecting the massive growth, that is happening at MOS, unnoticed

we are well worth a penny and there is no reason why we should not see that
when overhang is cleared, and we start getting regular update on numbers again

still holding tight, and looking forward to breaking that hard to break 0.40p again
and never look back..

GLA

ATB

speak soon

308..

C £82K buy someone is confident Hmmmmmmm

look like we will Defo see £3 again, perhaps before the day is out
who knows?? as this can move fast when more detail come to light..

see what happen

308..

he has kept us on the shelf for so long knowing that it works 100%
with all the readout they have given over the past few years on this compound
lot's of conference to get funding to progress it, as they had nothing else going for them
only to use them funding call to buy a failed P3 that they could never finish?

now they are getting $1.9 bill for the lot that inc our 737 and get out of paying us again
until GSK get it to Market?? criminal IMO, as 737 is GSK real target IMO''
and they are letting them get it on the cheap, through the back door...
there is nothing we can do about it, the BOD must never give our compound
to an unknown pharma ever again,

this story has got a long way to run, THO''

and the BOD should clarify or position a bit more than they have done in that
4pm RNS

what are they getting £1.9b for?? 737 was worth £334M on its own if it gets to Market?
that price would have trebled by now'' with GSK making an offer
for the only 2 drugs they have in there program

anyway lots to discuss, and as for the SP ATM, that should travel back over £3
in the day ahead as more press come online and more detail come to hand

308..

you can bet GSK is after a lot more than that ready made p3
that sierra bought from someone that could not be bothered with it

a steady rise back over £3 is expected

better late than never IMO, but perhaps a little to late
for the right impact, it should have been 2.30 - 3pm
but it is what it is, it's all in the open now that GSK is really
after SRA 737 but to get it they had to go through the back door

as SIERRA only got two program and one of them is us

let the speculating begin

see what the last trading day tomorrow brings as its bank holiday Friday,

SAR Twitter just now'' if it helps any''

Sareum Holdings plc
@Sareumplc
·
1h
SRA737 licence holder, Sierra Oncology, to be acquired by $GSK

$SAR.L Sareum #Chk1 #AIM #biotech

i shouldn't worry too much, as I'm sure they are wording the update as we speak

308..

SAR SRA 737 is one of only two assets in Sierra’s pipeline. Hmmmmmm
tells us that our compound is going to be worth a hell of a lot more
than we first thought?

without 1801 / 1802

we hot a huge mention in that link'' perhaps we are worth a lot more than the SP suggest ATM

"Sierra Oncology (NASDAQ:SRRA) complements our commercial and medical expertise in haematology,” said GSK’s chief commercial officer, Luke Miels.

“Momelotinib offers a differentiated treatment option that could address the significant unmet medical needs of myelofibrosis patients with anaemia, the major reason patients discontinue treatment.

“With this proposed acquisition, we have the opportunity to potentially bring meaningful new benefits to patients and further strengthen our portfolio of specialty medicines."

Keen students of the sector will remember that Sierra has licensed a drug candidate, SRA737, from UK tiddler Sareum Holdings PLC (AIM:SAR).

How this impacts the development of the Sareum-discovered checkpoint kinase 1 inhibitor is unknown at this stage.

It is one of only two assets in Sierra’s pipeline.

some press on this huge deal, with us tied in to it somewhere, i should imagine

https://www.proactiveinvestors.co.uk/companies/news/979626/glaxosmithkline-boosts-oncology-product-line-as-it-swoops-for-us-drug-developer-in-us-1-9bn-deal-979626.html

following the same pattern as yesterday, with big buyers
in the background another huge finish incoming IMO..
and if we don't get that update statement this afternoon

we can expect it in the morning for sure.. with 1 for the believers just now''

SKY news just now'' about the GSK deal..

well it is certainly going global if they have pick up on it''

the BOD will perhaps have to bring something shortly a statement perhaps??

good post PK''

we should have known GSK was going to buy them out, to get to SRA737
and and us eventually?? from there tie up with Sierra last year...

the BOD must already know it's going to happen very soon
that's why they was in such a hurry to consolidate???
as that would have been needed for a lot higher SP
if any deal between GSK and SAR was to be done

RNS has to come shortly to clarify there position, on this massive news
and that off SRA 737

308..

Parker retweet just now'' hope we get an RNS shortly

Stephen Parker Retweeted
Sierra Oncology
@sierraoncology
·
1h
$SRRA has entered into an agreement to be acquired by $GSK. This deal provides a clear path to delivering on our promise to myelofibrosis patients while delivering compelling and certain value for our stockholders. Read our press release for details http://bit.ly/3roYScW

GLA and I'm sure we will be back on another run to £4 soon and mirror yesterday

308..

what a start to the day we are having, never thought we would see that so quickly

drinks all round

so does that mean they will get out of paying us that
£500k milestone again LOL!! lucky BSTRDS

excellent news of progress, see if we can get back over 40
and keep it

hopefully catch up and pass that price in the not too distant
and end up buying them out LOL!!

slow A--SS outfit, god knows how they keep managing to get $100m
funding on tap, to wast while ignoring the only compound that works 100%
for years

hopefully SAR will get that pittance of just £500k milestone, they have been holding
back from paying, if they can somehow drag 737 to the clinic on time this time
with whatever Combo they chose

a few nice one at full ask 12.7k worth buy, at the price Hmmmm
i would expect the rise to continue on the bell tomorrow

we will see

but as always hope to see news at some point,